Recognition of Impact and contribution towards, Simandou 2040
“Initiatives like ODHAV Pharma enable Guinea to move toward self-sufficiency, create jobs, help people learn, and support the country’s journey toward development like other nations around the world.”
– Mr. Amadou Oury BAH, Prime Minister of Guinea
“The development of the pharmaceutical industry stands at the convergence of Guinea’s two major national ambitions — strengthening Industry & Trade through production, processing, and value creation, while advancing Health & Well-being through better access to care and improved healthcare quality.”
– Ms. Khaïté Sall, Health Minister of Guinea
Simandou 2040 Impact: 2 Key Pillars, 1 Major Step Toward Local Pharma Manufacturing & Healthcare Self-Sufficiency
ODHAV Pharma Guinée S.A.S. marks an important step in strengthening Guinea’s pharmaceutical industry and supporting the country’s Simandou 2040 vision for industrial growth, healthcare development, and local production.
Recognized by Guinea’s Health Minister and Prime Minister, the initiative connects Industry & Trade with Health & Well-being by improving local manufacturing, medicine availability, job creation, skill development, and healthcare self-sufficiency.
Through this contribution, ODHAV Pharma supports Guinea’s long-term goal of reducing import dependency and building a stronger, more sustainable healthcare and industrial future.
